FOOD AND DRUG ADMINISTRATION

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy.

A federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by a government agency more than two decades ago.

Three appeals court judges with a history of supporting restrictions on abortion will hear arguments May 17 on whether a widely used abortion drug should remain available.

The Food and Drug Administration has approved a new type of drug to treat hot flashes caused by menopause.

New blood donations rules will allow sexually active gay and bisexual men in monogamous relationships to give in the U.S. The Food and Drug Administration guidelines ease decades-old restrictions on blood donations put in place to protect the blood supply from HIV.

Federal health advisers are recommending that a decades-old birth control pill be sold without a prescription.

U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription.

The U.S. has approved the first vaccine for RSV, shots to protect older adults.

U.S. health officials have approved the first pill that uses healthy bacteria from human waste to prevent dangerous gut infections — an easier way of performing so-called fecal transplants.

U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease.

Nothing will change for now.

Nothing will change for now.

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.

The Supreme Court is leaving women’s access to an abortion pill untouched until at least Friday, while the justices consider whether to allow restrictions on mifepristone to take effect.

Lawyers for anti-abortion doctors are urging the Supreme Court to allow restrictions to take effect on a drug used in the most common method of abortion in the United States, while a lawsuit continues.

Older Americans and people with weak immune systems can get an extra COVID-19 booster dose this spring.

The Supreme Court is temporarily keeping in place federal rules for use of an abortion drug, while it takes time to more fully consider the issues raised in a court challenge.

Doctors, clinics and telehealth providers across the country are scrambling to figure out how they will continue to provide the most common type of abortion after a federal appeals court imposed new restrictions on a key abortion medication.

A federal appeals court has ruled that the abortion pill mifepristone can still be used for now but reduced the period of pregnancy when the drug can be taken and said it could not be dispensed by mail.

The Biden administration on Monday asked a federal appeals court to allow women to continue to be able to access to the most commonly used abortion drug in the U.S. while a lawsuit over it plays out.

The Justice Department is appealing a Texas court ruling that would halt approval of a drug used in the most common method of abortion in the U_S_ In its appeal Monday, the Justice Department called the decision “extraordinary and unprecedented.”.

The nation’s top health official says a court ruling threatening the availability of a main drug used in medication abortion was “not America.”.

A 19th century “anti-vice” law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act is being been revived by groups seeking to block the mailing of mifepristone, the pill used in more than half of U.S. abortions.

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market.

While Red Dye No. 3 adds vibrant color, Consumer Reports warns of potentially harmful health hazards and is questioning why companies are still allowed to put it in some of the things we eat.

U.S. health advisersare backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness.

A federal judge has heard arguments in a lawsuit that poses a threat to the nationwide availability of a popular abortion medication.

Medication abortions became the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade.

A conservative judge in Texas has raised questions about an effort to overturn the decades-old approval of a leading abortion drug, in a case that could threaten the country’s most common method to end pregnancies.

Migraine sufferers will soon have something new to try to relieve their headaches fast.

The maker of an unproven drug intended to prevent premature births says it will voluntarily remove the product from the United States.

The Biden administration is preparing for a worst-case scenario if a conservative federal judge rules in favor of a lawsuit seeking to ban one of the two drugs typically used to induce a medicated abortion.

The Food and Drug Administration is pledging a reset in the agency’s tobacco program.

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation.

The Nonprescription Drugs Advisory Committee (NDAC) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is discussing supplemental new drug application 208411/S–006, for NARCAN (naloxone hydrochloride) nasal spray, submitted by Emergent BioSolutions Inc.

A Texas lawsuit is posing a threat to the nationwide availability of medication abortion, which now accounts for the majority of abortions in the U.S. The case filed by abortion opponents who helped challenge Roe v. Wade seeks to reverse a decades-old approval by the Food and Drug Administration.

The head of the Food and Drug Administration has announced an overhaul of the agency's food safety and nutrition division.

The U.S. plans to make it easier for gay and bisexual men to give blood.

How often should Americans get their booster shot against COVID-19, and how important is the booster to you if you’ve already been infected with COVID-19? Those are questions a panel of experts set out to answer during an FDA meeting, the information will be passed on to the CDC.

The Food and Drug Administration's top food safety official has resigned.

U.S. health officials want to make COVID-19 vaccinations more like the annual flu shot.

Millions of people get sick each year from contaminated food and finding the source of the contamination isn’t easy. But that could be changing with a new plan aimed at reducing the number of foodborne illnesses and deaths.

A new Alzheimer’s drug is hitting the market with experts voicing a lot of caution.

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease.

People could soon get the abortion pill at retail pharmacies.

U.S. health officials have finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.

The Food and Drug Administration announced Friday that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy.

U.S. regulators have cleared doses of the updated COVID-19 vaccines for children younger than 5.

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs.

A panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health.

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5.

In a statement, the agency specifically mentioned risk-based screening for HIV.

U.S. officials approved the first pharmaceutical-grade version of the fecal transplant procedures that doctors have increasingly used to treat a potentially life-threatening intestinal infection.

A lawsuit against the maker of an anti-malarial drug blamed for causing psychotic and neurological damage in U.S. servicemembers has been thrown out.

A warning from the Food and Drug Administration — double-check before you buy from an online pharmacy.

Colorado voters have passed a ballot initiative to decriminalize psychedelic mushrooms for people 21 and older and to create state-regulated centers where participants can experience the drug.

Embattled vaping company Juul Labs is announcing layoffs as the company tries to navigate growing setbacks to its electronic cigarette business.

Trick-or-treating can be dangerous, but there are tools available to help protect your children.

Around Halloween, many parents worry about trick-or-treating safety, sugar crashes and ruined bedtimes. But there’s something you might not be thinking about but should be: toxic ingredients in your kids’ face paints and powders

A massive recall of sleep apnea machines is expected to drag into next year.

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax.

A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn't work.

The Food and Drug Administration has approved over-the-counter hearing aids to be sold at pharmacies and stores this month.

The maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work.

Consumer Reports explains everything you need to know about the new ways of shopping for a hearing aid.

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5.

U.S. regulators have revealed their plan to allow foreign baby formula manufactures to stay on the market long term.

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.

A new social media trend is encouraging young people to cook their poultry in the basic ingredients of Nyquil and other over the counter cough products.

U.S. health officials are warning doctors against overusing the lone drug available to treat monkeypox.

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease.

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days.

New COVID-19 boosters that target today's most common omicron strains are set to begin soon.

Florida has sued federal health officials, accusing them of stalling the state's plan to import lower-cost prescription drugs from Canada.

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday.

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.

The head of the Food and Drug Administration says a government review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help.

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.

U.S. regulators have issued a warning letter to the maker of illegal nicotine gummies.

U.S. regulators have finalized a long-awaited rule that's expected to allow millions of Americans to buy hearing aids without a prescription.

New U.S. recommendations call for three home tests for people exposed to COVID-19 to improve accuracy.

U.S. regulators say they are no longer considering authorizing second COVID-19 booster shots for all adults under 50 this summer.

Health regulators say nearly 800,000 doses of monkeypox vaccine will soon be available for U.S. distribution.

U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark.

The U.S. is getting another COVID-19 vaccine choice.

The Food and Drug Administration, along with the Centers for Disease Control and Prevention, is helping the Florida Department of Health and Florida Department of Agriculture and Consumer Services investigate a listeria outbreak linked to ice cream, the FDA said Tuesday.

A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription.

The Food and Drug Administration and Juul have agreed to put their court fight on hold while the government conducts more review of the company’s electronic cigarettes.

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients.

The Biden administration is looking to help foreign manufacturers of baby formula stay on the U.S. market for the long term.

The Food and Drug Administration has issued an administrative stay on the order it issued last month for vaping company Juul to pull its electronic cigarettes from the market.

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives.

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

A federal court has put a temporary hold on the government's order for Juul to stop selling its electronic cigarettes.

Health officials have ordered vaping company Juul to pull its electronic cigarettes from the U.S. market.

U.S. health regulators have ordered vaping company Juul to pull its electronic cigarettes from the market.